Article Versions Notes

Ratschker T, Egenberger L, Alev M, Zschiesche L, Band J, Schreiber E, Frey B, Derer A, Alexiou C, Janko C. Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy–Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells. Pharmaceutics. 2020; 12(10):923. https://doi.org/10.3390/pharmaceutics12100923

Ratschker, Teresa, Laura Egenberger, Magdalena Alev, Lisa Zschiesche, Julia Band, Eveline Schreiber, Benjamin Frey, Anja Derer, Christoph Alexiou, and Christina Janko. 2020. "Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy–Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells" Pharmaceutics 12, no. 10: 923. https://doi.org/10.3390/pharmaceutics12100923

Ratschker, T., Egenberger, L., Alev, M., Zschiesche, L., Band, J., Schreiber, E., Frey, B., Derer, A., Alexiou, C., & Janko, C. (2020). Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy–Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells. Pharmaceutics, 12(10), 923. https://doi.org/10.3390/pharmaceutics12100923